Antigenic Mimicry and Autoimmune Diseases

References

• Snell G. D. H-2 locus of the mouse: Observation and speculations concerning its comparative genetics and polymorphism. Folia Biol. Praha 1968; 14: 335–338
   PubMedGoogle Scholar
• Oldstone M. B. A. Molecular mimicry and autoimmune disease. Cell 1987; 50: 819–820
   Google Scholar
• Maizels R. M., Clarke J. A., Harvey M. A. Epitope specificity of the T cell proliferative response to lysozyme: Proliferative T cells react predominantly to different determinants from those recognized by B cells. Eur. J. Immunol 1980; 10: 509–515
   PubMedGoogle Scholar
• Haskins K., Kappler J., Marrack P. The major histocompatibility complex-restricted antigen receptor on T cells. Annu. Rev. Immunol 1984; 2: 51–66
   PubMed Web of Science ®Google Scholar
• Meuer S. C., Acuto O., Hercend T. The human T-cell receptor. Annu. Rev. Immunol 1984; 2: 23–50
   PubMed Web of Science ®Google Scholar
• Sredni B., Schwartz R. H. Alloreactivity of an antigen specific T cell clone. Nature 1980; 287: 855–857
   PubMedGoogle Scholar
• Atassi M. B. Immune recognition of proteins. Molecular Immunology, M. Z. Atassi, C. J. van Oss, D. R. Absolom. Marcel Dekker, New York 1984; 15–51
   Google Scholar
• Ajdukiewicz A. B., Dudley E. J., Fox R. A., Doniach D., Sherlock S. Immunological studies in an epidemic of infective, short incubation hepatitis. Lancet 1972; 1: 803–806
   PubMed Web of Science ®Google Scholar
• Linder E., Kurki P., Andersson L. C. Autoantibodies to “intermediate filaments” in infectious mononucleosis. Clin. Immunol. Immunopathol 1979; 14: 411–417
   PubMedGoogle Scholar
• Fong S., Tsoukas C. D., Frincke L. A., Lawrence S. K., Holbrook T. L., Vaughan J. H., Carson D. A. Age-associated changes in Epstein-Barr virus-induced human lymphocyte autoantibody responses. J. Immunol 1981; 126: 910–914
   PubMed Web of Science ®Google Scholar
• Toh H., Yildie A., Sotelo J., Osung O., Holborow E. J., Kanakoudi F, Small J. M. Viral infections and IgM autoantibodies to cytoplasmic intermediate filaments. Clin. Exp. Immunol 1979; 37: 76–82
   PubMedGoogle Scholar
• Lane D. P., Hoeffler W. K. SV40 large T shares an antigenic determinant with a cellular protein of molecular weight 68,000. Nature 1980; 288: 167–170
   PubMed Web of Science ®Google Scholar
• Dales S., Fujinami R. S., Oldstone M. B. A. Infection with vaccinia favors the selection of hybridomas synthesizing autoantibodies against intermediate filaments, one of them crossreacting with the virus hemagglutinin. J. Immunol 1983; 131: 1546–1553
   PubMed Web of Science ®Google Scholar
• Fujinami R. S., Oldstone M. B. A., Wroblewska Z., Frankel M. E., Koprowski H. Molecular mimicry in virus infection: crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments. Proc. Natl. Acad. Sci. USA 1983; 80: 2346–2350
   PubMed Web of Science ®Google Scholar
• Sotelo J., Gibbs C. J., Gajdusek D. C. Autoantibodies against axonal neurofilaments in patients with kuru and Creutzfeld-Jakob disease. Science 1979; 210: 190–193
   Google Scholar
• Sarin R. S., Sun D. K., Thornton A. H., Naylor R. H., Goldstein A. L. Neutralization of HTLV-III/LAV replication by antiserum to thymosin α1. Science 1986; 232: 1135–1137
   PubMed Web of Science ®Google Scholar
• Sheshberadaran H., Nouby E. Three monoclonal antibodies against measles virus F protein cross-react with cellular stress proteins. J. Virol 1984; 52: 995–999
   PubMedGoogle Scholar
• Minota S., Cameron B., Welch W. J., Winfield J. B. Autoantibodies to the constitutive 73-kD member of the hsp70 family of heat shock proteins in systemic lupus erythematosus. J. Exp. Med 1988; 168: 1475–1480
   PubMed Web of Science ®Google Scholar
• Muller S., Briand J. -P., Van Regenmortel M. H. V. Presence of antibodies to ubiquitin during the autoimmune response associated with systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 1988; 85: 8176–8180
   PubMedGoogle Scholar
• Fujinami R. S. Virus-induced autoimmunity through molecular mimicry. Ann. NY Acad. Sci 1988; 540: 210–217
   PubMedGoogle Scholar
• Oldstone M. B. S., Notkins A. L. Molecular mimicry. Concepts in Viral Pathogenesis, A. L. Notkins, M. B. A. Oldstone. Springer-Verlag, New York 1986; Vol. II: 195–202
   Google Scholar
• Srinivasappa J., Saegusa J., Prabhakar B. S., Gentry M. K., Buchmeier M. X., Wiktor T. J., Koprowski H., Oldstone M. B. A., Notkins A. L. Molecular mimicry: Frequency of reactivity of monoclonal antiviral antibodies with normal tissues. J. Virol 1986; 57: 397–401
   PubMed Web of Science ®Google Scholar
• Fujinami R. S., Nelson J. A., Walker L., Oldstone M. B. A. Sequence homology and irtununologic cross reactivity of human cytomegalovirus with HLA-DR ^ chain: A means for graft rejection and immunosuppression. J. Virol 1988; 62: 100–105
   PubMed Web of Science ®Google Scholar
• Clarke M. E., Gelmann E. P., Reitz M. S., Jr. Homology of human T-cell leukaemia virus envelope gene with class 1 HLA gene. Nature 1983; 305: 60–62
   PubMedGoogle Scholar
• Reither W. E., Blalock J. E., Brunck T. K. Sequence homology between acquired immunodeficiency syndrome virus envelope protein and interleukin 2. Proc. Natl. Acad. Sci. USA 1986; 83: 9188–9192
   PubMedGoogle Scholar
• Nemerow G. R., Mold C., Schwend V. K., Tollefson E., Cooper N. R. Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/63d receptor of B cells: Sequence homology of gp350 and C3 complement fragment C3d. J. Virol 1987; 61: 1416–1420
   PubMedGoogle Scholar
• Dyrberg T., Oldstone M. B. A. Peptides as probes to study molecular mimicry and virus induced autoimmunity. Curr. Top. Microbiol. Immunol 1986; 130: 25–37
   PubMedGoogle Scholar
• Walker E. J., Jeffrey R. D. Polymyositis and molecular mimicry, a mechanism of autoimmunity. Lancet 1986; 2: 605–607
   PubMed Web of Science ®Google Scholar
• Singh V. K., Yamaki K., Abe T., Shinohara T. Molecular mimicry between uveitopathogenic site of retinal S-antigen and Escherichia coli protein: induction of experimental autoimmune uveitis and lymphocyte cross-reaction. Cell. Immunol 1982; 122: 262–273
   Google Scholar
• Zwillich S. H., Lipsky P. E. Molecular mimicry in the pathogenesis of rheumatic diseases. Rheum. Dis. Clin. North Am 1987; 13: 339–352
   PubMedGoogle Scholar
• Hemachudha T., Griffin D. E., Giffels J. J. Myelin basic protein as an encephalitogen in encephalomyelitis and polyneuritis following rabies vaccination. N. Engl. J. Med 1987; 316: 369–374
   PubMed Web of Science ®Google Scholar
• Williams R. C., Jr. Molecular mimicry and rheumatic fever. Clin. Rheum. Dis 1985; 11: 573–590
   PubMedGoogle Scholar
• Kaplan M. H., Svec K. H. Immunologic relations of streptococcal and tissue antigens. III. Presence in human sera of streptococcal antibody crossreactive with heart tissue. Association with streptococcal infection, rheumatic fever, and glomerulonephritis. J. Exp. Med 1964; 119: 651–666
   PubMed Web of Science ®Google Scholar
• Zabriskie J. B., Hsu K. C., Seegal B. C. Heart-reactive antibody associated with rheumatic fever: characterization and diagnostic significance. Clin. Exp. Immunol 1970; 7: 147–159
   PubMed Web of Science ®Google Scholar
• Dale J. B., Beachey E. H. Protective antigenic determinant of streptococcal M protein shared with sarcolemmal membrane protein of human heart. J. Exp. Med 1982; 156: 1165–1176
   PubMed Web of Science ®Google Scholar
• Krisher K., Cunningham M. W. Myosin: a link between streptococci and heart. Science 1985; 227: 413–415
   PubMed Web of Science ®Google Scholar
• Cunningham M. W., Hall N. K., Krisher K. K. A study of anti-group A streptococcal monoclonal antibodies cross-reactive with myosin. J. Immunol 1986; 136: 293–298
   PubMed Web of Science ®Google Scholar
• Dale J. B., Beachey E. H. Epitopes of streptococcal M proteins shared with cardiac myosin. J. Exp. Med 1986; 162: 583–591
   Google Scholar
• Goldstein I., Halpern B., Robert L. Immunological relationship between streptococcus A polysaccharide and the structural glycoproteins of heart valve. Nature 1967; 213: 44–47
   Web of Science ®Google Scholar
• Dudding B. A., Ayoub E. M. Persistence of streptococcal group A antibody inpatients with rheumatic valvular disease. J. Exp Med 1968; 128: 1081–1098
   PubMed Web of Science ®Google Scholar
• Husby G., van de Rijn I., Zabriskie J. B., Abdin Z. H., Williams R. C., Jr. Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever. J. Exp. Med 1976; 144: 1094–1110
   PubMed Web of Science ®Google Scholar
• Fillet H., Damie S. P., Gregory J. D. Sera from patients with poststreptococcal glomerulonephritis contain antibodies to glomerular heparan sulfate proteoglycan. J. Exp. Med 1985; 161: 277–289
   PubMedGoogle Scholar
• Couchman J. R., Caterson B., Christner J. E., Baker J. R. Mapping by monoclonal antibody of glycosaminoglycans in connective tissues. Nature 1984; 307: 650–652
   PubMed Web of Science ®Google Scholar
• Kraus W., Ohyama K., Snyder D. S., Beachey E. H. Autoimmune sequence of streptococcal M protein shared with the intermediate filament protein, vimentin. J. Exp. Med 1989; 169: 481–492
   PubMed Web of Science ®Google Scholar
• Johnson R. T., Griffin D. E., Hirsch R. L., Wolinsky J. S., Roedenbeck S., Lindo de Soriano I., Vaisberg A. Measles encephalomyelitis: Clinical and immunological studies. N. Engl. J. Med 1984; 310: 137–141
   PubMed Web of Science ®Google Scholar
• Fujinami R. S., Oldstone M. B. A. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science 1985; 230: 1043–1045
   PubMed Web of Science ®Google Scholar
• Johnson R. T., Griffin E. D. Virus-induced autoimmune demyelinating disease of the central nervous system. Concepts in Viral Pathogenesis, A. L. Notkins, M. B. A. Oldstone. Springer-Verlag, New York 1986; Vol. II: 203–209
   Google Scholar
• Lisak R. R., Zweiman B. In vitro cell-mediated immunity of cerebrospinal fluid lymphocytes to myelin basic protein in primary demyelinating diseases. N. Eng. J. Med 1977; 291: 850–853
   Google Scholar
• Kagnoff M. E., Paterson Y. J., Kumar R. J., Kasarda D. D., Carbone F. R., Unsworth D. J., Austin R. K. Evidence for the role of a human intestinal adenovirus in the pathogenesis of coeliac disease. Gut 1987; 28: 995–1001
   PubMed Web of Science ®Google Scholar
• Kagnoff M. F., Austin R. K., Hubert J. J., Bernardin J. B., Kasarda D. D. Possible role for a human adenovirus in the pathogenesis of celiac disease. J. Exp. Med 1984; 160: 1544–1557
   PubMed Web of Science ®Google Scholar
• Lindstrom J. M., Seybold M. E., Lennon V. A., Whittingham S., Duane D. D. Antibody to acetylcholine receptor in myasthenia gravis: Prevalence, clinical correlates and diagnostic value. Neurology 1976; 26: 1054–1059
   PubMed Web of Science ®Google Scholar
• Lennon V. A., McCormick D. J., Lambert E. H., Griesmann G. E., Atassi M. Z. Region of peptide 125–147 of acetylcholine receptor a subunit is exposed at neuromuscular junction and induces experimental autoimmune myasthenia gravis, T-cell immunity, and modulating autoantibodies. Proc. Natl. Acad. Sci. USA 1985; 82: 8805–8809
   PubMed Web of Science ®Google Scholar
• Datta S. K., Schwartz R. S. Infectious (?) myasthenia. N. Engl. J. Med 1974; 291: 1304–1305
   PubMedGoogle Scholar
• Lindstrom J. Immunobiology of myasthenia gravis, experimental autoimmune myasthenia gravis, and Lambert-Eaton syndrome. Annu. Rev. Immunol 1985; 3: 109–131
   PubMed Web of Science ®Google Scholar
• Pearson C. M. Development of arthritis, periarthritis and periostitis in rats given adjuvants. Proc. Soc. Exp. Bio. Med 1956; 91: 95–101
   PubMed Web of Science ®Google Scholar
• Pearson C. M., Waksman B. H., Sharp J. T. Studies of arthritis and other lesions induced in rats by injection of mycobacterial adjuvant. J. Exp. Med 1961; 113: 485–510
   PubMed Web of Science ®Google Scholar
• van Eden W., Holoschitz J., Nevo Z. Arthritis induced by a T lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans. Proc. Nad. Acad. Sci. USA 1985; 82: 5117–5120
   PubMed Web of Science ®Google Scholar
• van Eden W., Thole J. E., van der Zee R. Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature 1988; 331: 171–173
   PubMed Web of Science ®Google Scholar
• Polla B. S. A role for heat shock proteins in inflammation?. Immunology Today 1988; 9: 134–137
   PubMedGoogle Scholar
• Gaston J. S. H., Life P. F., Jenner P. J., Colston M. J., Bacon P. A. Recognition of a mycobacteria-specific epitope in the 65-kD heat-shock protein by synovial fluid-derived T cell clones. J. Exp. Med 1990; 171: 831–841
   PubMed Web of Science ®Google Scholar
• Fox R. I., Lotz M., Rhodes G., Vaughan J. H. Epstein-Barr virus in rheumatoid arthritis. Clinics Rheum. Dis 1985; 11: 665–688
   PubMedGoogle Scholar
• Fox R., Sportsman R., Rhodes G., Lukas J., Pearson G., Vaughan J. H. Rheumatoid arthritis synovial membrane contains a 62,000 molecular weight protein that shares an antigenic epitope with the Epstein-Barr virus-encoded associated nuclear antigen. J. Clin. Invest 1986; 77: 1539–1547
   PubMed Web of Science ®Google Scholar
• Luka J., Kreofsky T., Pearson G. R., Hennessy K., Kieff E. Identification and characterization of a cellular protein that crossreacts with the Epstein-Barr virus nuclear antigen. J. Virol 1984; 52: 833–838
   PubMedGoogle Scholar
• Sulitzeanu D., Anafi M. EBV. molecular mimicry and rheumatoid arthritis: a hypothesis. Immunol. Lett 1889; 20: 89–92
   Google Scholar
• Vaughan J. H., Kouri T., Peterson J., Roudier J., Rhodes G. H. On the etiology of Rheumatoid Arthritis. Scand. J. Rheum 1988; 74: 19–28, suppl.
   Google Scholar
• Roudier J., Rhodes R., Petersen J., Vaughan J. H., Carson D. A. The Epstein-Barr virus glycoprotein gu110, a molecular link between HLA-DR4, HLA-DRl and rheumatoid arthritis. Scand. J. Immunol 1988; 27: 367–371
   PubMed Web of Science ®Google Scholar
• Gregersen R. K., Silver J., Winchester R. J. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1978; 30: 1205–1213
   Google Scholar
• Res R. C. M., Schaar C. G., Breedveld E. C., van Eden W., van Embden J. D. A., Cohen I. R., de Vries R. R. P. Synovial fluid T cell reactivity against 65 kD heat shock protein of mycobacteria in early chronic arthritis. Lancet 1988; 2: 478–480
   PubMed Web of Science ®Google Scholar
• Ottenhof T. H. M., Torres P., Terencio de las Aguas J., Fernandez R., van Eden W., de Vries R. R. R, Stanford J. L. Evidence for a HLA-DR4-associated immune response gene for Mycobacterium tuberculosis: a clue to the pathogenesis of rheumatoid arthritis?. Lancet 1986; 2: 310–312
   PubMedGoogle Scholar
• Wood J. N., Hudson L., Jessell T. M., Yamamoto M. A monoclonal antibody defining antigenic determinants on subpopulations of mammalian neurons and Trypanosoma cruzi parasites. Nature 1982; 296: 34–38
   PubMedGoogle Scholar
• Acosta A. M., Santos-Buch C. A. Autoimmune myocarditis induced by. Trypanosoma cruzi. Lab. Invest 1985; 71: 1255–1261
   Google Scholar
• Retry K., Voison P., Bahz T. Complex lipids as common antigens to Trypanosoma cruzi, T. dionisii, T. vespertilionis, and nervous tissue (astrocytes, neurons). Acta Trop 1987; 44: 381
   PubMedGoogle Scholar
• Acosta A. M., Sadigursky M., Santos-Buch C. A. Anti-striated muscle antibody activity produced by. Trypanosoma cruzi. Proc. Sac. Exp. Biol. Med 1983; 172: 364
   PubMedGoogle Scholar
• Brewerton D. A. HLA-B27 and the inheritance of susceptibility to rheumatic disease. Arthritis Rheum 1976; 19: 656–668
   PubMed Web of Science ®Google Scholar
• Schlosstein L., Terasaki P. I., Bluestone R., Pearson C. M. High association of an HL-A antigen, w27, with ankylosing spondylitis. N. Engl. J. Med 1973; 288: 704–706
   PubMed Web of Science ®Google Scholar
• Eastmond C. J., Woodrow J. C. Discordance for ankylosing spondylitis in monocytic twins. Ann. Rheum. Dis 1977; 36: 360–364
   PubMed Web of Science ®Google Scholar
• Aho K., Ahvonen R., Lassus A., Sievers K., Tiilikainen A. HL-A27 in reactive arthritis. A study of Yersinia arthritis and Reiter's disease. Arthritis Rheum 1974; 17: 521–526
   PubMed Web of Science ®Google Scholar
• Inman R. D. The interplay of microbe and MHC in the pathogenesis of Reiter's syndrome. Clin. Exp. Rheum 1986; 4: 75–82
   PubMed Web of Science ®Google Scholar
• Ebringer A. The cross tolerance hypothesis and B27 disease. Br J. Rheum 1983; 22(suppl 2)53
   PubMedGoogle Scholar
• Edmonds J., Macauley D., Tyndall A., Liew M., Alexander K., Geczy A., Bashir H. Lymphocytotoxicity of anti-Klebsiella antisera in ankylosing spondylitis and related arthropathies. Arth. Rheum 1981; 24: 1–7
   PubMedGoogle Scholar
• Nakbin B., Brewerton D. A., Byrom N., James D. C. O., Makla S., McLeod L., Slater L., Warren R. E., Hobbs J. R. Lymphocyte function in ankylosing spondylitis. Ann. Rheum. Dis 1975; 34(suppl 1)49–52
   PubMedGoogle Scholar
• Granfors K. Measurement of immunoglobulin M (IgM), IgG and IgA antibodies against Yersinia entero-colitica by enzyme-linked immunosorbent assay. J. Clin. Microbiol 1979; 9: 336–341
   PubMed Web of Science ®Google Scholar
• Granfors K., Viljanen M., Tiilikainen A., Toivanen A. Persistence of IgM, IgG and IgA antibodies to Yersinia in Yersinia arthritis. J. Infect. Dis 1980; 141: 424–429
   PubMed Web of Science ®Google Scholar
• Trull A., Ebringer A., Panayi G., Ebringer R., James D. C. O. HLA-B27 and the immune response to enterobacterial antigens in ankylosing spondylitis. Clin. Exp. Immunol 1984; 55: 74–80
   PubMed Web of Science ®Google Scholar
• Keat A., Thomas B., Dixley J., Osborn M., Sonnex C., Taylor-Robinson D. Chlamydia Trachomatis and reactive arthritis: the missing link. Lancet 1987; 1: 72–74
   PubMed Web of Science ®Google Scholar
• Granfors K., Jalkanen S., von Essen R., Lahesmaa-Rantala R., Isomaki O., Pekkola-Heino K., Merilahti-Palo R., Saario R., Isomaki H., Toivanen A. Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N. Engl. J. Med 1989; 320: 216–221
   PubMed Web of Science ®Google Scholar
• Toivanen A., Lahesmaa-Rantala R., Stahlberg T. H., Merilahti-Palo R., Granfors K. Do bacterial antigens persist in reactive arthritis?. Clin. Exp. Rheum 1987; 5/5–1: 25–21
   Google Scholar
• Keat A. Reiter's syndrome and reactive arthritis in perspective. N. Engl. J. Med 1983; 309: 1606–1615
   PubMed Web of Science ®Google Scholar
• Ebringer A., Cowling R., Ngwa Suh N., James D. C. O., Ebringer R. W. Cross-reactivity between Klebsiella aerogenes species and B27 lymphocyte antigens as an aetiological factor in ankylosing spondylitis. HLA and Disease, J. Dausset, A. Svejgaard. INSERM, Paris 1976; 27
   Google Scholar
• McGuigan L. E., Prendergast J. K., Geczy A. E., Edmonds J. R., Bashir H. V. Significance of nonpathogenic crossreactive bowel flora in patients with ankylosing spondylitis. Ann. Rheum. Dis 1986; 45: 566–571
   PubMedGoogle Scholar
• Eastmond C. J., Willshaw H. E., Burgess S. E. R., Shinebaum R., Cooke E. M., Wright V. Frequency of fecal Klebsiella aerogenes in patients with ankylosing spondylitis and controls with respect to individual features of the disease. Ann. Rheum. Dis 1980; 39: 118–123
   PubMed Web of Science ®Google Scholar
• Warren R. E., Brewerton D. A. Faecal carriage of Klebsiella in patients with ankylosing spondylitis and rheumatoid arthritis. Ann. Rheum. Dis 1980; 39: 37–44
   PubMed Web of Science ®Google Scholar
• Geczy A. E., Alexander K., Bashir H. V., Edmonds J. R., Upfold L., Sullivan J. HLA-B27 Klebsiella and ankylosing spondylitis: biological and chemical studies. Immunol. Rev 1983; 70: 23–50
   PubMed Web of Science ®Google Scholar
• Sullivan J. S., Geczy A. F. An antiserum to a disease-associated factor from the cells of an HLA-B27 positive patient with ankylosing spondylitis specifically recognizes an HLA-B27 associated determinant. Arth. Rheum 1987; 30: 439–442
   PubMedGoogle Scholar
• Ogasawara M., Kono D. H., Yu D. T. Y. Mimicry of human histocompatibility HLA-B27 antigens by Klebsiella pneumoniae. Infect. Immun 1986; 51: 901–908
   PubMed Web of Science ®Google Scholar
• van Bohemen C. G., Grumet E. C., Zanen H. C. Identification of HLA-B27 Ml and M2 crossreactive antigens in Klebsiella, Shigella and Yersinia. Immunology 1984; 52: 607–610
   PubMed Web of Science ®Google Scholar
• Beaulieu A. D., Rousseau E., Israel-Assayag E., Roy R. Klebsiella related antigens in ankylosing spondylitis. J. Rheumatol 1983; 10: 102–105
   PubMedGoogle Scholar
• Singh B., Milton J. D., Woodrow J. C. Ankylosing spondylitis, HLA-B27 and klebsiella; A study of lymphocyte reactivity of anti-klebsiella sera. Ann. Rheum. Dis 1986; 45: 190–197
   PubMedGoogle Scholar
• Cameron E. H., Russell R. J., Easter J. F., Wakefield D., March L. Failure of Klebsiella pneumoniae antibodies to crossreact with peripheral blood mononuclear cells from patients with ankylosing spondylitis. Arth. Rheum 1987; 30: 300–305
   PubMedGoogle Scholar
• Trapani J. A., McKenzie I. E. C. Klebsiella ‘modifying factor’ binding studies with HLA-B27+ and B27- lymphocytes. Ann. Rheum. Dis 1985; 44: 169–175
   PubMedGoogle Scholar
• Edmonds J., Geczy A. E., Sullivan J. S., Prendergast J. K., Upfold L. I., Bashir H. V. Enteric bacteria and HLA-B27 associated cell surface modification in patients with seronegative spondarthritis. Br. J. Rheum 1983; 22(suppl 2)75–82
   PubMedGoogle Scholar
• Prendergast J. K., Sullivan J. S., Geczy A., Upfold L. I., Edmonds J. P., Bashir H. V., Reiss-Levy E. Possible role of enteric organisms in the pathogenesis of ankylosing spondylitis and other seronegative arthropathies. Infect. Immun 1983; 41: 935–941
   PubMedGoogle Scholar
• Prendergast J. K., McGuigan L. E., Geczy A. E., Kwong T. S. L., Edmonds J. P. Persistence of HLA-B27 crossreactive bacteria in bowel floral of patients with ankylosing spondylitis. Infect. Immun 1984; 46: 686–689
   PubMed Web of Science ®Google Scholar
• Wakefield D., Easter J., Robinson R., Graham D., Penny R. Chlamydial antibody crossreactivity with peripheral blood mononuclear cells of patients with ankylosing spondylitis: the role of HLA-B27. Clin. Exp. Immunol 1986; 63: 49–57
   PubMedGoogle Scholar
• Pease P. E., Balmer S. E., Tallack J. E., Chahal H., Ibbotson J., Bartlett L. R., Lane M., Allan R. N. Further observations upon HLA-B27, Yersinia enterocolilica and ankylosing spondylitis. Ann. Rheum. Dis 1986; 45: 526–528
   PubMedGoogle Scholar
• Kono D. H., Park M. S., Yu D. T. Y., Granfors K., Toivanen A. Absence of lymphotoxic antibodies in patients with Yersinia-induced arthritis, Reiter's syndrome and ankylosing spondylitis. Clin. Exp. Rheum 1984; 2: 303–307
   PubMedGoogle Scholar
• Inman R. D., Chui B., Johnston M. E. A., Falk J. Molecular mimicry in Reiter's syndrome: cytotoxicity and ELISA studies of HLA-microbial relationships. Immunology 1986; 58: 501–506
   PubMedGoogle Scholar
• Roudier J., De Montclos H., Thouvenot D., Chomel J. J., Guillermet E N., Betuel H. Absence of cross-reaction between HLA–B27 and Yersinia enterocolitica or chlamydia tracheomatis in reactive arthritis and ankylosing spondylitis. Clin. Rheum 1985; 4: 487
   PubMed Web of Science ®Google Scholar
• Cameron E. H., Russell R. J., Sullivan J., Geczy A. E. Is a Klebsiella plasmid involved in the aetiology of ankylosing spondylitis in HLA-B27-positive individuals?. Mol. Immun 1983; 20: 563–566
   PubMed Web of Science ®Google Scholar
• Kono D. H., Ogasawara M., Effros R. B., Park M. S., Walford R. L., Yu D. T. Y. Ye-1, a monoclonal antibody that crossreacts with HLA-B27 lymphoblastoid cell lines and an arthritis causing bacteria. Clin. Exp. Immunol 1985; 61: 503–508
   PubMed Web of Science ®Google Scholar
• Raybourne R. B., Bunning V. K., Williams K. M. Reaction ofanti-HLA-B monoclonal antibodies with envelope proteins of Shigella species: Evidence for molecular mimicry in the spondyloarthropathies. J. Immunol 1988; 140: 3489–3495
   PubMed Web of Science ®Google Scholar
• Chen J. H., Kono D. H., Yong Z., Park M. S., Oldstone M. B. A., Yu D. T. Y. A Yersinia pseudotuberculosis protein which cross-reacts with HLA-B27. J. Immunol 1987; 139: 3003–3011
   PubMed Web of Science ®Google Scholar
• Schwimmbeck P. L., Yu D. T. Y., Oldstone M. B. A. Autoantibodies to HLA-B27 in the sera of HLA-B27 patients with ankylosing spondylitis and Reiter's syndrome. J. Exp. Med 1987; 166: 173–181
   PubMed Web of Science ®Google Scholar
• Tsuchiya N., Husby G., Williams R. C., Jr. Studies of humoral and cell-mediated immunity to peptides shared by HLA-27.1 and Klebsiella pneumoniae nitrogenase in ankylosing spondylitis. Clin. Exp. Immunol 1989; 76: 354–360
   PubMed Web of Science ®Google Scholar
• Husby G., Tsuchiya N., Schwimmbeck R. L., Keat A., Pahle J. A., Oldstone M. B. A., Williams R. C., Jr. Crossreactive epitope with Klebsiella pneumoniae nitrogenase in articular tissue of HLA-B27+ patients with ankylosing spondylitis. Arth. Rheum 1989; 32: 437–445
   PubMed Web of Science ®Google Scholar
• Yu D. T. Y., Chao S. Y., Schaack T. Molecular mimicry in HLA-B27-related arthritis. Ann. Intern. Med 1989; 111: 581–591
   PubMed Web of Science ®Google Scholar
• Stieglitz H., Foxmire S., Lipsky R. Identification of a 2-Md plasmid from Shigella flexneri associated with reactive arthritis. Arthritis Rheum 1989; 32: 937–946
   PubMedGoogle Scholar
• Lahesmaa-Rantala R., Skurnik M., Gransfors K., Mottonen T., Saario R., Toivanen A., Toivanen P. A. tetrapeptide shared by Yersinia outer membrane protein Yopl and HLA-B27; immune response in patients with Yersinia–triggered reactive arthritis. Advances in Technology: The Molecular Basis of Immune Diseases, E. Streilein. ICSU Press. 1990; 76
   Google Scholar
• Pullen A. M., Marrack P., Kappler J. W. The T-cell repertoire is heavily influenced by tolerance to polymorphic self-antigens. Nature 1988; 335: 796–801
   PubMed Web of Science ®Google Scholar
• MacDonald H. R., Schneider R., Lees R. K., Howes R. C., Acha-Orbea H., Festenstein H., Zinker-nagel R. M., Hengartner H. T-cell receptor Vβ use predicts reactivity and tolerance to M1saencoded antigens. Nature 1988; 332: 40
   PubMed Web of Science ®Google Scholar
• Callahan J. E., Herman A., Kappler J. W., Marrack P. Stimulation of B10.BR T cells with super-antigenic staphylococcal toxins. J. Immunol 1990; 144: 2473–2479
   PubMedGoogle Scholar
• Cole B. C., Kartchner D. R., Wells D. J. Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritides. VII. Responsiveness is associated with expression of a product(s) of the Vβ8 gene family present on the T cell receptor α/β for antigen. J. Immunol 1989; 142: 4131–4137
   PubMedGoogle Scholar
• Dobersen M. J., Scharff J. E., Ginsberg-Fellner E., Notkins A. L. Cytotoxic autoantibodies to beta cells in the serum of patients with insulin-dependent diabetes mellitus. N. Eng. J. Med 1980; 303: 1493–1498
   PubMed Web of Science ®Google Scholar
• Lange C. E. Immunology of aging. Prog. Clin. Path 1978; 7: 119–136
   PubMedGoogle Scholar
• Guilbert B., Dighiero G., Avrameas S. Naturally occurring antibodies against nine common antigens in human sera. J. Immunol 1982; 128: 2779–2787
   PubMed Web of Science ®Google Scholar
• Alexander H., Johnson D. A., Rosen J., Jerabek L., Green N., Weissman I. L., Lerner R. A. Mimicking the alloantigenicity of proteins with chemically synthesized peptides differing in single amino acids. Nature 1983; 306: 697–699
   PubMedGoogle Scholar